Michelle Sar B Devlin
Examiner (ID: 9913)
Most Active Art Unit | 2936 |
Art Unit(s) | 2936 |
Total Applications | 96 |
Issued Applications | 95 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8653073
[patent_doc_number] => 08372822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 13/486688
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 16279
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486688
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/486688 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | May 31, 2012 | Issued |
Array
(
[id] => 8394196
[patent_doc_number] => 20120232039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/412032
[patent_app_country] => US
[patent_app_date] => 2012-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20757
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412032 | Primary amine diazeniumdiolate heterocyclic derivatives | Mar 4, 2012 | Issued |
Array
(
[id] => 8336320
[patent_doc_number] => 20120203021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS'
[patent_app_type] => utility
[patent_app_number] => 13/342469
[patent_app_country] => US
[patent_app_date] => 2012-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7218
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342469
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/342469 | Method for producing cyanoacrylate esters in the presence of transition metal catalysts | Jan 2, 2012 | Issued |
Array
(
[id] => 8410480
[patent_doc_number] => 08273877
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-09-25
[patent_title] => 'Substituted tetraazapentalenes'
[patent_app_type] => utility
[patent_app_number] => 13/373540
[patent_app_country] => US
[patent_app_date] => 2011-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4778
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13373540
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/373540 | Substituted tetraazapentalenes | Nov 17, 2011 | Issued |
Array
(
[id] => 8664180
[patent_doc_number] => 08377641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Fluorescence quenching azo dyes, their methods of preparation and use'
[patent_app_type] => utility
[patent_app_number] => 13/298479
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7890
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/298479 | Fluorescence quenching azo dyes, their methods of preparation and use | Nov 16, 2011 | Issued |
Array
(
[id] => 7744614
[patent_doc_number] => 20120022124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/198214
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 16250
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022124.pdf
[firstpage_image] =>[orig_patent_app_number] => 13198214
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/198214 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | Aug 3, 2011 | Issued |
Array
(
[id] => 7587587
[patent_doc_number] => 20110282097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'ISOMERIZED ALPHA OLEFIN SULFONATE AND METHOD OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/194243
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5663
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20110282097.pdf
[firstpage_image] =>[orig_patent_app_number] => 13194243
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194243 | Isomerized alpha olefin sulfonate and method of making the same | Jul 28, 2011 | Issued |
Array
(
[id] => 8043835
[patent_doc_number] => 20120071653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Human Adam-10 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/167128
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14321
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071653.pdf
[firstpage_image] =>[orig_patent_app_number] => 13167128
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167128 | Human Adam-10 Inhibitors | Jun 22, 2011 | Abandoned |
Array
(
[id] => 8543659
[patent_doc_number] => 08318951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Stem cell differentiating agents and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 13/116574
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 28926
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116574 | Stem cell differentiating agents and uses therefor | May 25, 2011 | Issued |
Array
(
[id] => 6064897
[patent_doc_number] => 20110201792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'SYNTHESIS OF AZO BONDED IMMUNOREGULATORY COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/094135
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5620
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201792.pdf
[firstpage_image] =>[orig_patent_app_number] => 13094135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094135 | Synthesis of azo bonded immunoregulatory compounds | Apr 25, 2011 | Issued |
Array
(
[id] => 6017141
[patent_doc_number] => 20110224412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'Analogues Of 1,3-Bis(4-Nitrophenyl)Triazenes, Their Pharmaceutically Acceptable Salts And N-Acyl Derivatives For Tumour Treatment'
[patent_app_type] => utility
[patent_app_number] => 13/090978
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4350
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224412.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090978
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090978 | Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment | Apr 19, 2011 | Issued |
Array
(
[id] => 6167816
[patent_doc_number] => 20110196008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/089482
[patent_app_country] => US
[patent_app_date] => 2011-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 16229
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196008.pdf
[firstpage_image] =>[orig_patent_app_number] => 13089482
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/089482 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | Apr 18, 2011 | Issued |
Array
(
[id] => 8442520
[patent_doc_number] => 20120259137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'COMPOSITION, SYNTHESIS, AND USE OF ISONITRILES'
[patent_app_type] => utility
[patent_app_number] => 13/080179
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4030
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13080179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/080179 | Composition, synthesis, and use of isonitriles | Apr 4, 2011 | Issued |
Array
(
[id] => 6064330
[patent_doc_number] => 20110201610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'ARYL SULFONAMIDES'
[patent_app_type] => utility
[patent_app_number] => 13/045209
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40768
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201610.pdf
[firstpage_image] =>[orig_patent_app_number] => 13045209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045209 | ARYL SULFONAMIDES | Mar 9, 2011 | Abandoned |
Array
(
[id] => 6064330
[patent_doc_number] => 20110201610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'ARYL SULFONAMIDES'
[patent_app_type] => utility
[patent_app_number] => 13/045209
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40768
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201610.pdf
[firstpage_image] =>[orig_patent_app_number] => 13045209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045209 | ARYL SULFONAMIDES | Mar 9, 2011 | Abandoned |
Array
(
[id] => 8313625
[patent_doc_number] => 20120190651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'ANTI-INFLAMMATORY COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/012463
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6681
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012463 | Anti-inflammatory compounds | Jan 23, 2011 | Issued |
Array
(
[id] => 6102662
[patent_doc_number] => 20110166155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators'
[patent_app_type] => utility
[patent_app_number] => 12/985681
[patent_app_country] => US
[patent_app_date] => 2011-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16536
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12985681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/985681 | Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators | Jan 5, 2011 | Abandoned |
Array
(
[id] => 8701593
[patent_doc_number] => 08394815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => '2,4,5-trisubstituted imidazoles and their use as anti-microbial agents'
[patent_app_type] => utility
[patent_app_number] => 12/976122
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16431
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12976122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/976122 | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents | Dec 21, 2010 | Issued |
Array
(
[id] => 8592020
[patent_doc_number] => 08349897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Biphenyloxyacetic acid derivatives for the treatment of respiratory disease'
[patent_app_type] => utility
[patent_app_number] => 12/973395
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15907
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12973395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/973395 | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | Dec 19, 2010 | Issued |
Array
(
[id] => 6214130
[patent_doc_number] => 20110136802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'SHIP1 MODULATORS AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/960318
[patent_app_country] => US
[patent_app_date] => 2010-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29844
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136802.pdf
[firstpage_image] =>[orig_patent_app_number] => 12960318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/960318 | SHIP1 modulators and methods related thereto | Dec 2, 2010 | Issued |